Weave at DIA Global Annual Meeting — Booth 1218
Weave is exhibiting at DIA 2026, where we’ll be showcasing how human-driven AI supports complex, document-intensive work across regulatory and clinical teams. Stop by to see how AI helps organize and connect source information, streamline drafting and review cycles, and provide clear visibility into document evolution—while keeping subject matter experts firmly in control.
Don’t miss our talks:
Monday, June 15 | 1:05 – 1:35 PM | Track 03: Data-Tech-AI
Session Title:
The connected submission: How AI, automation, and intelligence are changing the regulatory ecosystem
Session Description:
Regulatory teams are being asked to move faster while maintaining consistency and quality across increasingly complex submissions. Disconnected authoring processes and inconsistent standards make this difficult to scale.
In this session, we explore how AI-enabled authoring, process standardization, and automation come together to support a more connected submission approach. Drawing from real-world experience, we’ll walk through how these elements can improve speed and consistency, and how connecting them enables new forms of regulatory intelligence to support more proactive planning and decision-making.
We’ll also share practical frameworks for implementing these capabilities within existing processes—what to change, what to keep, and how to approach adoption across teams.
Speakers:
Brandon Rice, CEO and Co-founder, Weave Bio
Katie Connelly, SVP, Global Head of Regulatory Affairs, Parexel
Tuesday, June 16 | 9:15 – 9:45 AM | Innovation Theater:
Session Title:
Threading AI Throughout the Drug Development Lifecycle: An Enterprise Lens
Session Description:
Enterprise pharma teams face increasing pressure to move faster while maintaining the quality and consistency required for complex health authority interactions. Fragmented workflows and evolving data make this especially challenging at scale.
In this session, we share real-world lessons from working with partners on how a unified, human-driven AI approach can support more consistent, efficient narrative development across the lifecycle. We’ll walk through key considerations for selecting, designing, and implementing AI within existing processes—along with where to adapt workflows and where to preserve them.
Speakers:
Brandon Rice, CEO and Co-founder, Weave Bio
Andrew S. Robertson, Ph.D., JD, Vice President and Head of Global Regulatory Policy & Innovation, Takeda
